Evidence map›Paper›PMID 36628514›Full record

ArticleThe American journal of psychiatry2023

Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma.

Ziv Ben-Zion, Tobias R Spiller, Jackob N Keynan, Roee Admon, Ifat Levy, Israel Liberzon, Arieh Y Shalev, Talma Hendler, Ilan Harpaz-Rotem

Open access · greenAbstract read
In one paragraph

Article in The American journal of psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Post-traumatic stress disorder: evolving conceptualization and evidence, and future research directions.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  9. Review
  10. Review
  11. Defining theNature. Mental health · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ziv Ben-ZionYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Tobias R SpillerYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Jackob N KeynanYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Roee AdmonYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Ifat LevyYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Israel LiberzonYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Arieh Y ShalevYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Talma HendlerYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
Ilan Harpaz-RotemYale School of Medicine (Ben-Zion, Spiller, Levy, Harpaz-Rotem) and Wu Tsai Institute and Department of Psychology (Levy, Harpaz-Rotem), Yale University, New Haven; U.S. Department of Veterans Affairs National Center for PTSD Clinical Neuroscience Division, VA Connecticut Healthcare System, West Haven (Ben-Zion, Spiller, Harpaz-Rotem); Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Ben-Zion, Shalev, Hendler), Sagol School of Neuroscience (Ben-Zion, Hendler), and Faculty of Social Sciences and Sackler Faculty of Medicine (Hendler), Tel Aviv University, Tel Aviv, Israel; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich (Spiller); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (Keynan); School of Psychological Sciences and Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel (Admon); Department of Psychiatry, College of Medicine, Texas A&M University, College Station (Liberzon); Department of Psychiatry, NYU Grossman School of Medicine, New York (Shalev).
National Center for PTSD · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Neurobehavioral Moderators of Post-traumatic Disease TrajectoriesR01MH103287 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHALEV, ARIEH Y · 2014 to 2018
$2.7M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH103287
6 · The paper itself

Abstract

objectiveThe weak link between subjective symptom-based diagnostic methods for posttraumatic psychopathology and objectively measured neurobiological indices forms a barrier to the development of effective personalized treatments. To overcome this problem, recent studies have aimed to stratify psychiatric disorders by identifying consistent subgroups based on objective neural markers. Along these lines, a promising 2021 study by Stevens et al. identified distinct brain-based biotypes associated with different longitudinal patterns of posttraumatic symptoms. Here, the authors conducted a conceptual nonexact replication of that study using a comparable data set from a multimodal longitudinal study of recent trauma survivors.

methodsA total of 130 participants (mean age, 33.61 years, SD=11.21; 48% women) admitted to a general hospital emergency department following trauma exposure underwent demographic, clinical, and neuroimaging assessments 1, 6, and 14 months after trauma. All analyses followed the pipeline outlined in the original study and were conducted in collaboration with its authors.

resultsTask-based functional MRI conducted 1 month posttrauma was used to identify four clusters of individuals based on profiles of neural activity reflecting threat and reward reactivity. These clusters were not identical to the previously identified brain-based biotypes and were not associated with prospective symptoms of posttraumatic psychopathology.

conclusionsOverall, these findings suggest that the original brain-based biotypes of trauma resilience and psychopathology may not generalize to other populations. Thus, caution is warranted when attempting to define subtypes of psychiatric vulnerability using neural indices before treatment implications can be fully realized. Additional replication studies are needed to identify more stable and generalizable neuroimaging-based biotypes of posttraumatic psychopathology.

Indexed as

Stress Disorders, Post-TraumaticAdultBrainFemaleHumansLongitudinal StudiesMaleNeuroimagingProspective StudiesBiological MarkersNeuroimagingNeurosciencePosttraumatic Stress Disorder (PTSD)Replication StudyStress

Identifiers

PMID36628514
PMCPMC9898083
OpenAlexW4315620767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.